Management of Stable Chronic Obstructive Pulmonary Disease: A Systematic Review for a Clinical Practice Guideline

Figure 3. Number of participants who had at least 1 exacerbation: inhalation treatments versus active control.

LABA = long-acting β₂-agonist; NA = not applicable; RR = relative risk; SABA = short-acting β₂-agonist.